Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Becton, Dickinson and Company Appoints Joseph M. Smith as Senior Vice President, Chief Scientific Officer and Co-Chair of Scientific Advisory Board

11/29/2021 | 06:50am EST

Becton, Dickinson and Company announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific officer for the company, effective November 29, 2021. In this role, Smith will be primarily responsible for external innovation and the company?s technology roadmap to deliver transformative innovations that align to three irreversible forces driving the future of health care: smart connected care, the transition to new care settings and chronic disease. Smith will lead a reinvigorated focus on external technology partnerships and oversee the development of new innovation models. Smith will also establish and co-chair the company?s Scientific Advisory Board (SAB), which will be comprised of top external medical key opinion leaders, science and technology experts and experienced innovation leaders. Smith reports to Elizabeth McCombs, executive vice president and chief technology officer for the company. Smith joins the company from Digital Health Corp, where he served as president and CEO. He also served as president for a digital transformation consultancy, providing business, technology and clinical insight to medical device and diagnostics companies. During his career, Smith has held medical, scientific and technology leadership positions at multiple organizations including Johnson & Johnson, Boston Scientific and the West Health Institute. Smith is a member of the board of directors at four, private companies including Constant Therapy Health, Inc; EP Sciences Inc.; PDS Inc.; and Ocudyne Inc.


ę S&P Capital IQ 2021
All news about BECTON, DICKINSON AND COMPANY
01/27BD - New Study Finds Up to One-Third of Women Receive Clinical Misdiagnosis of Vaginiti..
AQ
01/27BD Recognized for Equality by Bloomberg, Human Rights Campaign
PR
01/26BECTON DICKINSON AND : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
01/26BECTON DICKINSON & CO : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
01/26New Study Finds Up to One-Third of Women Receive Clinical Misdiagnosis of Vaginitis
PR
01/25BD Board Declares Dividend
PR
01/25Becton, Dickinson and Company Declares Quarterly Dividend, Payable on March 31, 2022
CI
01/25Becton, Dickinson to Seek Acquisitions
CI
01/20BD Innovation Profiled in Cover Story of 'Science' Demonstrates Landmark Advancement in..
PR
01/12BD Named One of America's Most Just Companies in Annual JUST 100 Ranking
AQ
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 19 459 M - -
Net income 2022 2 337 M - -
Net Debt 2022 12 756 M - -
P/E ratio 2022 31,9x
Yield 2022 1,51%
Capitalization 71 600 M 71 600 M -
EV / Sales 2022 4,34x
EV / Sales 2023 4,04x
Nbr of Employees 75 000
Free-Float 77,4%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 251,19 $
Average target price 274,15 $
Spread / Average Target 9,14%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY0.96%71 600
ABBOTT LABORATORIES-14.42%206 551
MEDTRONIC PLC-0.26%138 731
HOYA CORPORATION-18.59%44 518
BAXTER INTERNATIONAL INC.-1.41%42 374
SARTORIUS STEDIM BIOTECH-24.07%37 655